# Truffle Capital

> Truffle Capital is a VC fund backing Biotechnology and Financial Services. See 59 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Paris, France
- Total investments: 59
- Last investment: Jun 2026
- Lead investor: 51%
- Fund size: $143M
- Last fund: Dec 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/truffle-capital
- X (Twitter): http://twitter.com/trufflecapital
- Website: http://www.truffle.com
- Facebook: https://www.facebook.com/trufflecapital

Truffle Capital is an independent, European venture capital firm focused on disruptive technologies in IT (FinTech and InsurTech) and Life Sciences (BioTech and MedTech). Truffle Capital aims to support the creation and growth of young innovative companies with the potential to become tomorrow’s market leaders. Chaired by Patrick Kron, alongsidethe company’s founders and CEOs, Philippe Pouletty and Bernard-Louis Roques, Truffle Capital raised over $1 billion and has supported over 75 companies since its creation, in the digital technologies and life sciences sectors.At the end of 2017, Truffle Capital successfully completed the first close of its two new institutional funds, Truffle Financial Innovation Fund and Truffle BioMedTech Fund, as well as the first close of a fund dedicated to the French Reserve Fund (« Fonds de Réserve pour les Retraites » or « FRF »).On May 2019, Truffle Capital is a company of 24 professionals from various nationalities (French, Italian, English, Chinese…), passionated by the trade of financing innovation.

## Contacts

5 contacts available for Truffle Capital. Shizune tracks 11 team members at Truffle Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/truffle-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $2.2M–$13M |
| Series B | $3.3M–$50M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 13 | 22% |
| Financial Services | 11 | 19% |
| Health Care | 9 | 15% |
| Software | 8 | 14% |
| FinTech | 7 | 12% |

73 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 15 | 25% |
| Series A | 14 | 24% |
| Series B | 11 | 19% |
| Seed | 6 | 10% |
| Series C | 3 | 5% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 27 | 46% |
| United States | 4 | 7% |
| Belgium | 2 | 3% |
| Switzerland | 2 | 3% |
| The Netherlands | 2 | 3% |

11 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Antoine Pau | Partner | 0 | https://shizune.co/investors/profile/antoine-pau |
| Faranaz Auliar | Philippe Pouletty Executive Assistant | 0 | https://shizune.co/investors/profile/faranaz-auliar |
| Jean-Claude Caducal | CEO Circle, Life Sciences | 0 | https://shizune.co/investors/profile/jean-claude-caducal |
| Michel Finance | Venture Partner | 2 | https://shizune.co/investors/profile/michel-finance |
| Miguel Sieler | Venture Partner | 0 | https://shizune.co/investors/profile/miguel-sieler |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Seacure | Géocorail développe et commercialise un produit innovant faisant travailler la mer à la protection du littoral : le Géocorail®. Ce procédé électrochimique breveté innovant consiste à créer une roche artificielle permettant de protéger les ouvrages marins et de lutter contre l’érosion du littoral. | $8.5M | Venture - Series Unknown | Jun 08, 2026 |  |
| Hydrosat | Hydrosat is a deep-tech company using thermal satellite data and AI to address society's most urgent challenges. We provide geospatial intelligence for food production, security, and natural resource management. | $60M | Series B | Jan 15, 2026 |  |
| Wyden | AlgoTrader is the global institutional leader in algorithmic trading and execution infrastructure for both digital and traditional assets. With its advanced software solutions, AlgoTrader gives banks, hedge funds, brokers, crypto funds and other financial institutions an end-to-end platform for best execution and event-driven alpha generation. Thecompany's offering includes WIRESWARM, a digital asset trading and connectivity platform for banks and brokers, AlgoTrader QUANT, an end-to-end quantitative trading solution with automated trade signal generation and order execution, and AlgoTrader OEMS, a state-of-the-art Order and Execution Management System for systematic and discretionary buy-side institutions with managed connectivity to over 400 liquidity venues. AlgoTrader’s interdisciplinary team of quantitative strategy developers, senior software engineers and financial and crypto experts is shaping institutional trading. Founded in Switzerland and based in Zurich, New York and Singapore, AlgoTrader operates globally. | $16.9M | Series B | Nov 12, 2024 |  |
| DgPays | Dgpays are into fintech which provides end-to-end payment system for Banks, E-Money Institutions, Telecom and Transportation Operators. | $50M | Series B | Feb 27, 2024 |  |
| Levenue | Levenue is built to help European founders with unlocking that value, positioning revenue as a new asset class. We are creating the largest European revenue-based finance marketplace that transforms recurring revenues into upfront cash instantly. We connect institutional investors with founders/ CFO’S on our platform. So that founders can getback to what really matters, focusing on their company. We provide recurring revenue companies with growth capital without diluting shareholders, or without the need for high consumer discounts, by leveraging on revenues. | $8.7M | Series A | Nov 15, 2023 |  |
| Obat | Obat supplies contractors and independent contractors with invoicing software. The tool is constantly changing depending on input from customers and partners. | $12.8M | Series A | Nov 09, 2023 |  |
| MoneyTrack | MoneyTrack is a global, decentralized blockchain platform for Directed Money. | $2.2M | Series A | Jan 12, 2023 |  |
| Obat | Obat supplies contractors and independent contractors with invoicing software. The tool is constantly changing depending on input from customers and partners. | $6M | Seed | Sep 18, 2022 |  |
| Abivax | Abivax is a clinical-stage biotechnology company, that mobilizes the body’s natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer. Their aim is to use Abivax's drug development platforms to provide novel and effective treatments to patients with large unmet needs in these therapeutic areas. | $49M | Post-IPO Equity | Sep 02, 2022 |  |
| Bridge | Bridge is a banking data and payment system. They offer banking aggregation, payment initiation, open data, electronic invoices, debt collection, e-commerce sites and digital and physical commerce, factoring, kitty service, wallets, single and multiple payments, finance and insurance, credit, risk, and fraud experts. | $20.3M | Series A | Jul 07, 2022 |  |

10 of 59 investments shown.

## Co-investors
- [Evolem Start](https://shizune.co/investors/profile/evolem-start) — VC Fund, 5 deals together
- [Novartis Venture Fund](https://shizune.co/investors/profile/novartis-venture-fund) — VC Fund, 5 deals together
- [AG2R La Mondiale](https://shizune.co/investors/profile/ag2r-la-mondiale) — VC Fund, 3 deals together
- [HealthCap](https://shizune.co/investors/profile/healthcap) — VC Fund, 3 deals together
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 2 deals together
- [Freshmen Fund](https://shizune.co/investors/profile/freshman-fund-a746) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Global Founders Capital](https://shizune.co/investors/profile/global-founders-capital) — VC Fund
- [Coinbase Ventures](https://shizune.co/investors/profile/coinbase-ventures) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Financial Services VC Funds in France](https://shizune.co/investors/financial-services-vc-funds-france)
- [FinTech Investors in France](https://shizune.co/investors/fintech-investors-france)
- [FinTech VC Funds in France](https://shizune.co/investors/fintech-vc-funds-france)
- [Biotechnology Investors in France](https://shizune.co/investors/biotechnology-investors-france)
- [Biotechnology VC Funds in France](https://shizune.co/investors/biotechnology-vc-funds-france)
- [Biotech Investors in France](https://shizune.co/investors/biotech-investors-france)

## FAQ

### What does Truffle Capital invest in?

Truffle Capital invests primarily in Biotechnology, Financial Services and Health Care startups, most often at Funding Round and Series A stage. Most of the 59 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Truffle Capital's check size?

Truffle Capital typically joins rounds of $2.2M–$13M at Series A and $3.3M–$50M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Truffle Capital participates in.

### How do I contact Truffle Capital?

Public channels for Truffle Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Truffle Capital?

The team at Truffle Capital includes Antoine Pau (Partner), Faranaz Auliar (Philippe Pouletty Executive Assistant) and Jean-Claude Caducal (CEO Circle, Life Sciences), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co